1980
DOI: 10.1213/00000539-198007000-00008
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Reflex Sympathetic Dystrophy with Regional Intravenous Reserpine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0
1

Year Published

1987
1987
2004
2004

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 28 publications
(8 citation statements)
references
References 0 publications
0
7
0
1
Order By: Relevance
“…Chemical sympathetic denervation enhances the synthesis of IL-1ß and IL-6 in rats, suggesting a tonic inhibitory control of the sympathetic nerves on these inflammatory cytokines [13]. Several other studies also support that sympathetic nerves have anti-inflammatory effects [14][15][16].…”
Section: Introductionmentioning
confidence: 89%
“…Chemical sympathetic denervation enhances the synthesis of IL-1ß and IL-6 in rats, suggesting a tonic inhibitory control of the sympathetic nerves on these inflammatory cytokines [13]. Several other studies also support that sympathetic nerves have anti-inflammatory effects [14][15][16].…”
Section: Introductionmentioning
confidence: 89%
“…Es sei an die akute Zosterneuralgie erinnert, bei der diese Therapie zumeist wirksam ist, obgleich keine sympathische Dysfunktion besteht [6,90]. Weiterhin gibt es eine Vielzahl von Hinweisen, daß der sympathikolytische Effekt, also die Vasodilatation oder die Hemmung der Sudomotorik, ohnehin nicht mit der Dauer oder dem Ausmaß der Analgesie nach einer Sympathikusblockade oder nach der IVRS in Verbindung steht [12,18,66,67,100,120]. Die Analgesie kann persistieren, auch wenn sympathische Reflexe bereits wieder auslösbar sind [35].…”
Section: Störungen Der Sensibilitätunclassified
“…Treatment methods gaining popularity include the IV regional block technique (Bier block) employing reserpine, guanethidine, and bretylium as well as nifedipine, a calcium channel blocker, as a vasodilator [81][82][83][84][85][86][87].…”
Section: Nerve Blocksmentioning
confidence: 99%
“…Intravenous or intra-arterial infusion of ganglionic blocking agents into the affected extremity have recently gained prominence in the treatment of type I CRPS [81,83,85]. There are two reasons why IV administration of ganglionic blockers is superior to intra-arterial injection for treatment in this syndrome.…”
Section: Intravenous Regional Blockmentioning
confidence: 99%